When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. If You're Living With Asthma, Here's Every Single Treatment ...

   www.aol.com/youre-living-asthma-heres-every...

   While developing asthma as an adult is less common than getting it as a kid, asthma rates for people of all ages are rising—one in 12 adults has asthma, according to the latest figures from the ...

3. Asthma - Wikipedia

   en.wikipedia.org/wiki/Asthma

   Asthma phenotyping and endotyping has emerged as a novel approach to asthma classification inspired by precision medicine which separates the clinical presentations of asthma, or asthma phenotypes, from their underlying causes, or asthma endotypes. The best-supported endotypic distinction is the type 2-high/type 2-low distinction.

4. Anti-asthmatic agent - Wikipedia

   en.wikipedia.org/wiki/Anti-asthmatic_agent

   An anti-asthmatic agent, also known as an anti-asthma drug, refers to a drug that can aid in airway smooth muscle dilation to allow normal breathing during an asthma attack or reduce inflammation on the airway to decrease airway resistance for asthmatic patients, or both. The goal of asthmatic agents is to reduce asthma exacerbation frequencies ...

5. Pathophysiology of asthma - Wikipedia

   en.wikipedia.org/wiki/Pathophysiology_of_asthma

   The Centers for Disease Control and Prevention estimate that 1 in 11 children and 1 in 12 adults have asthma in the United States of America. [1] According to the World Health Organization, asthma affects 235 million people worldwide. [2] There are two major categories of asthma: allergic and non-allergic.

6. Nearly 1 in 10 Americans have asthma. Here's what causes it.

   www.aol.com/nearly-1-10-americans-asthma...

   While prevalence is likely higher due to the fact that asthma can go undiagnosed and untreated, nearly 1 in 10 adults living in the United States likely has the condition per the U.S. Centers for ...

7. Tezepelumab - Wikipedia

   en.wikipedia.org/wiki/Tezepelumab

   Tezepelumab, sold under the brand name Tezspire, is a human monoclonal antibody used for the treatment of asthma. [5] [7] [8] [9] Tezepelumab blocks thymic stromal lymphopoietin (TSLP), [5] an epithelial cytokine that has been suggested to be critical in the initiation and persistence of airway inflammation.